Company intelligence / Profile preview

5N Plus

Montreal, Quebec, Canada5nplus.com ↗

Ownership: Private
Development stage: Commercial

Overview

5N Plus does not conduct clinical trials or have a drug pipeline. It manufactures high-purity specialty semiconductors and performance materials—including APIs like bismuth compounds—used by pharmaceutical companies for commercialized medicines and medical devices. Its Lübeck facility operates under GMP standards with US FDA approval for pharma supply.

Therapeutic areas: GastroenterologyOther
Modalities: Active Pharmaceutical Ingredients (APIs)Bismuth Chemicals
Industry: Chemicals & Materials

Partnerships

First Solar

Beyond the preview

Go deeper on 5N Plus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5N Plus.

Explore the full profile